688136 科兴制药
2024/06 - 中期
人民币(K¥)
2023/12
人民币(K¥)
2022/12
人民币(K¥)
2021/12
人民币(K¥)
2020/12
人民币(K¥)
经营活动产生之现金流量净额(34,029)(87,135)(85,888)94,013105,931
投资活动产生之现金流量净额(121,378)(156,247)(381,446)(492,496)(200,554)
筹资活动产生之现金流量净额32,83316,247371,096186,9381,035,972
汇率变动对现金及现金等价物的影响9713,0955,432(2,066)(3,319)
现金及现金等价物净增加/(减少)(121,602)(224,040)(90,806)(213,612)938,030
期初现金及现金等价物余额559,931783,971874,7771,088,389150,359
期末现金及现金等价物余额438,328559,931783,971874,7771,088,389